Journal of Obesity and Metabolic Research

ORIGINAL ARTICLE
Year
: 2016  |  Volume : 3  |  Issue : 1  |  Page : 11--15

Study of atherosclerotic risk markers in patients with nonalcoholic fatty liver disease


Ritu Karoli, Jalees Fatima, Vaibhav Shukla, Ahraz Ahmad Khan, Mahima Pandey, Ritu Mishra 
 Department of Medicine, ERA's Lucknow Medical College, Lucknow, Uttar Pradesh, India

Correspondence Address:
Ritu Karoli
Department of Medicine, ERA«SQ»s Lucknow Medical College, Sarfarazganj, Hardoi Road, Lucknow - 226 003, Uttar Pradesh
India

Introduction: Nonalcoholic fatty liver disease (NAFLD) is described as hepatic component of metabolic syndrome as close association exists between the two. It has gained lots of importance in midst of rising epidemic of obesity worldwide in recent times as one of the predisposing risk factors of cardiovascular events. Study Design: The study design was a cross-sectional hospital-based study. Materials and Methods: Forty-eight patients diagnosed to have NAFLD were assessed for insulin resistance (IR) and noninvasive markers of subclinical atherosclerosis and compared with age, gender, and body mass index-matched controls. Results: The patients with NAFLD had significantly higher waist circumference, diastolic blood pressure, fasting insulin, homeostasis model assessment-IR, and significantly lower levels of high-density lipoprotein-cholesterol. They also had significantly higher carotid intima media thickness (CIMT) than controls. Mean CIMT was 0.76 ± 0.12 mm in patients with NAFLD and 0.54 ± 0.18 mm in controls. This difference was statistically significant (P = 0.001). The mean increase in brachial artery diameter was 0.26 ± 0.13 mm in patients and 0.48 ± 0.09 mm in controls. Conclusion: Patients with NAFLD have greater propensity to develop cardiovascular disease in view of the presence of subclinical atherosclerotic markers compared to controls.


How to cite this article:
Karoli R, Fatima J, Shukla V, Khan AA, Pandey M, Mishra R. Study of atherosclerotic risk markers in patients with nonalcoholic fatty liver disease.J Obes Metab Res 2016;3:11-15


How to cite this URL:
Karoli R, Fatima J, Shukla V, Khan AA, Pandey M, Mishra R. Study of atherosclerotic risk markers in patients with nonalcoholic fatty liver disease. J Obes Metab Res [serial online] 2016 [cited 2018 Dec 12 ];3:11-15
Available from: http://www.jomrjournal.org/article.asp?issn=2347-9906;year=2016;volume=3;issue=1;spage=11;epage=15;aulast=Karoli;type=0